Genmab
GMAB
#1148
Rank
NZ$33.42 B
Marketcap
NZ$53.91
Share price
1.00%
Change (1 day)
43.30%
Change (1 year)

EPS for Genmab (GMAB)

EPS in 2025 (TTM): NZ$3.02

According to Genmab's latest financial reports the company's current EPS (TTM) is NZ$3.10. In 2024 the company made an earnings per share (EPS) of NZ$21.09 an increase over its 2023 EPS that were of NZ$11.50.

EPS history for Genmab from 2002 to 2025

Annual EPS

Year EPS Change
2025 (TTM)NZ$3.02-85.69%
2024NZ$21.0983.39%
2023NZ$11.50-21.09%
2022NZ$14.5783.59%
2021NZ$7.94-36.99%
2020NZ$12.60112.21%
2019NZ$5.9443.15%
2018NZ$4.1532.47%
2017NZ$3.13-8.52%
2016NZ$3.4251.95%
2015NZ$2.25143.93%
2014NZ$0.92143.18%
2013NZ$0.38-120.79%
2012NZ-$1.83-20.33%
2011NZ-$2.2985.47%
2010NZ-$1.24-68.19%
2009NZ-$3.884.12%
2008NZ-$3.73147.94%
2007NZ-$1.50-22.56%
2006NZ-$1.94-10.56%
2005NZ-$2.17-19.76%
2004NZ-$2.719.49%
2003NZ-$2.47-33.35%
2002NZ-$3.71